CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs

Unlike other breast cancer subtypes, triple-negative breast cancer (TNBC) has no specific targets and is characterized as one of the most aggressive subtypes of breast cancer that disproportionately accounts for the majority of breast cancer-related deaths. Current conventional chemotherapeutics tar...

Descripción completa

Detalles Bibliográficos
Autores principales: Sulaiman, Andrew, McGarry, Sarah, Han, Xianghui, Liu, Sheng, Wang, Lisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721464/
https://www.ncbi.nlm.nih.gov/pubmed/31394796
http://dx.doi.org/10.3390/cancers11081128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721464/
https://www.ncbi.nlm.nih.gov/pubmed/31394796
http://dx.doi.org/10.3390/cancers11081128

Ejemplares similares